skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

89 studies were found about ( saquinavir OR Invirase )

A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment

Condition: HIV Infections

NCT ID: NCT00002334

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Condition: HIV Infections

NCT ID: NCT00000892

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

Condition: HIV Infections

NCT ID: NCT00002111

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00051831

A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00002374

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00002378

A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease

Condition: HIV Infections; AIDS-Associated Nephropathy

NCT ID: NCT00002397

Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002229

A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002382

A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002367

The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Condition: HIV Infections

NCT ID: NCT00002380

A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine

Condition: HIV Infections

NCT ID: NCT00002333

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001094

A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children

Condition: HIV Infections

NCT ID: NCT00000913

A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002448

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00400738

Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00000906

A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00002190

A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002383

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

Condition: HIV Infections

NCT ID: NCT00002178

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Condition: HIV Infections

NCT ID: NCT00002184

The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-Infected Pregnant Women.

Condition: HIV Infections

NCT ID: NCT00145561

A Study to Compare Two Anti-HIV Drug Combinations

Condition: HIV Infections

NCT ID: NCT00002447

A PK and Salvage Study for Children With HIV-infection

Condition: HIV Infections

NCT ID: NCT00476359

Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000920

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Condition: HIV Infections

NCT ID: NCT00038519

The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection

Condition: HIV Infections

NCT ID: NCT00002347

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Condition: HIV Infections

NCT ID: NCT00038532

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

Condition: HIV Infections

NCT ID: NCT00122603

GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00105079

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Condition: HIV Infections

NCT ID: NCT00001133

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Condition: HIV Infections

NCT ID: NCT00307502

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00207948

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Condition: HIV Infections

NCT ID: NCT00005762

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

Condition: HIV Infections

NCT ID: NCT00435929

A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children.

Condition: HIV Infections

NCT ID: NCT00623597

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Condition: HIV Infections

NCT ID: NCT00084058

A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT01638650

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

Condition: HIV Infections

NCT ID: NCT00035932

Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection

Condition: HIV Infections

NCT ID: NCT01297127

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00043953

The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002425

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Condition: HIV Infections

NCT ID: NCT00004584

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001087

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

Condition: HIV Infections

NCT ID: NCT00000848

Lopinavir Capsules to Kaletra or Invirase Tablets

Condition: HIV Infections

NCT ID: NCT00438152

A Study of 141W94 in Combination With Other Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002372

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Condition: HIV Infections

NCT ID: NCT00000941

Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function

Condition: Human Immunodeficiency Virus (HIV) Infection

NCT ID: NCT00717067

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00056641

Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC

Condition: HIV Infections

NCT ID: NCT00001040

Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r

Condition: HIV Infections

NCT ID: NCT00476502

Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

Condition: HIV Infections

NCT ID: NCT00379405

A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study

Condition: HIV Infections

NCT ID: NCT00192608

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

Condition: HIV Infections

NCT ID: NCT00389402

The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir

Condition: HIV Infections

NCT ID: NCT00000898

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

Condition: HIV Infections

NCT ID: NCT00002162

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002440

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

Condition: HIV Infections

NCT ID: NCT00000918

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00000912

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

Condition: HIV Infection

NCT ID: NCT00100984

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Condition: HIV Infections

NCT ID: NCT00046033

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Condition: HIV Infections

NCT ID: NCT00000891

Directly Observed Therapy in High Risk Populations in Newark, NJ

Condition: Directly Observed Therapy; HIV Infections

NCT ID: NCT00285883

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Condition: HIV Infections

NCT ID: NCT00001108

Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®

Condition: HIV Infections

NCT ID: NCT00622141

Pharmacokinetics of Low Dose Ritonavir

Condition: HIV Infections

NCT ID: NCT00622206

Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers

Condition: Healthy; HIV Infections

NCT ID: NCT00050180

A Prospective Cohort of Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00476606

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART

Condition: HIV Infections

NCT ID: NCT00000874

A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Condition: HIV Infections

NCT ID: NCT00000914

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00002213

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00411957

Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

Condition: ADHD; HIV

NCT ID: NCT01232361

Capravirine to Treat Children With HIV Infection

Condition: HIV Infection

NCT ID: NCT00006519

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00032669

Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

Condition: Human Immunodeficiency Virus

NCT ID: NCT01814722

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects

Condition: Acquired Immune Deficiency Syndrome (AIDS); HIV Infections

NCT ID: NCT02016924

A Phase 2 Study of the Safety of Ritonavir-Boosted Elvitegravir Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00445146

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents

Condition: HIV-1

NCT ID: NCT00665847

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Condition: HIV-1 Infection

NCT ID: NCT01252940

Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension

Condition: Pulmonary Arterial Hypertension

NCT ID: NCT02023450

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

Condition: IDV Associated Nephrotoxicity

NCT ID: NCT00477048

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

Condition: Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID

NCT ID: NCT00476983

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00003008